Stay updated on Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page
- Check4 days agoChange DetectedLocations section now lists Maryland as a study site. The footer has been updated to Revision: v3.3.3 and the old Maryland Locations entry and HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing Revision: v3.2.0. This is a metadata update and does not alter the study content or page functionality.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the government funding notice about updates and operating status (cc.nih.gov and opm.gov) — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedNo additions or deletions were detected; the study page content and layout appear unchanged.SummaryDifference0.4%

- Check82 days agoChange DetectedMajor update: announces funding-related service caveats and confirms NIH Clinical Center is open, plus version increment to v3.2.0; drops the old v3.1.0 reference.SummaryDifference3%

- Check89 days agoChange DetectedUpdated page to revision v3.1.0 with new contact details (phone numbers and emails) replacing the previous v3.0.2; core content remains largely the same, with emphasis on updated versioning and new contact information.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page.